Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
62-49-7
Molecular formula
C5H14NO+
Molecular weight
104.17 g/mol
Drug class
Essential nutrientprecursor of phosphatidylcholine and acetylcholine
Mechanism of action
Provides a methyl-group donor and precursor for phosphatidylcholine, sphingomyelin and acetylcholine synthesis. Choline is required for membrane integrity, lipid transport, methylation reactions and cholinergic neurotransmission.
Indications / reported uses
Prevention and correction of dietary choline deficiency through nutritional intake or supplementation; no general therapeutic drug indication should be inferred from its essential nutrient role
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Choline PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Choline Permitted Daily Exposure (PDE) report (the Choline PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Choline Occupational Exposure Limit (OEL) report (the Choline OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.